HOME > DLA BIZNESU > Oferty technologiczne

Oferty technologiczne

We commercialize innovative technologies which possess high potential to meet the needs of scientists of the modern economy. Our main source of inventions are Institutes of Ochota Biocentre consortium, highly experienced in conducting research at the highest level. Presented below solutions exhibit high commercial potential and deliver solutions for competetive advantage of companies.

Title: RNA restriction enzymes

International Institute of Molecular and Cell Biology (IIMCB), the leading institute in molecular biology in Poland, is looking for an industrial partner capable of commercialising revolutionary enzymes able to cut RNA strand(s) with sequence specificity.

More about this technology offer

***

Title: Safe and efficient Enzyme against S. aureus

Top class International Institute of Molecular and Cell Biology is looking for the partner to benefit from commercial exploitation of the innovative enzyme for fighting against bacteria contamination eg. S. aureus.

More about this technology offer

***

Title: Genetic tools for improvement of plant tolerance to poor soil conditions

Researchers from the Institute of Biochemistry and Biophysics, Polish Academy of Sciences (IBB PAS) have developed transgenic plants with advantageous breeding features, particularly with increased tolerance to abiotic stresses included by soil minerals alterations.

More about this technology offer

***

Title: Innovative Influenza Vaccine

Top class Institute of Biochemistry and Biophysics is looking for a partner for development and commercial exploitation of the innovative vaccine for influenza.
Institute is looking for the initial investment of £ 100 000 to enable preclinical studies

More about this technology offer

***

Title: Innovative compounds for Cystic Fibrosis treatment

Top class Institute of Biochemistry and Biophysics from Poland is looking for the partner to fund and benefit from commercial exploitation of the novel and innovative compound for Cystic Fibrosis treatment.
Institute is looking for the investment of $200 000 to progress with drug through preclinical studies.

More about this technology offer

***

Title: A new medication for Parkinson’s Disease and related disorders

Top class Institute of Mossakowski Medical Research Centre is looking for the partner for development and commercial exploitation on the innovative medication for Parkinson’s Disease.
Institute is looking for the initial investment of $150 000 to enable pre-clinical studies.

More about this technology offer

PRACUJEMY DLA:

BioCentrum Ochota

Instytut Biochemii i Biofizyki PAN Instytut Biologii Doświadczalnej im. M. Nenckiego PAN Instytut Medycyny Doświadczalnej i Klinicznej PAN Isntytut Biocybernetyki i Inżynierii Biomedycznej PAN Instytut Podstawowych Problemów Techniki PAN

Projekt współfinansowany ze środków Unii Europejskiej w ramach Europejskiego Funduszu Społecznego
Niniejszy serwis nie zbiera w sposób automatyczny żadnych informacji, za wyjątkiem informacji zawartych w plikach cookies. Przez używanie stron niniejszego serwisu wyrażasz zgodę na używanie ciasteczek zgodnie z naszą polityką. Jeżeli nie zgadzasz się na stosowanie cookies przez nasz serwis, powinieneś zmienić ustawienia swojej przeglądarki w odpowiedni sposób lub zrezygnować z używania stron tej witryny. X